Australia - English - Department of Health (Therapeutic Goods Administration)

jshealth vitamins pty ltd - cyanocobalamin, quantity: 75 microgram; biotin, quantity: 500 microgram; pyridoxal 5-phosphate monohydrate, quantity: 23.51 mg (equivalent: pyridoxine, qty 15 mg); ascorbic acid, quantity: 100 mg; magnesium citrate, quantity: 154.7 mg (equivalent: magnesium, qty 25 mg); riboflavin, quantity: 30 mg; pyridoxine hydrochloride, quantity: 18.23 mg (equivalent: pyridoxine, qty 15 mg); zingiber officinale, quantity: 5 mg (equivalent: zingiber officinale, qty 55 mg); potassium iodide, quantity: 287.8 microgram (equivalent: iodine, qty 220 microgram); chromic chloride hexahydrate, quantity: 256.4 microgram (equivalent: chromium, qty 50 microgram); thiamine hydrochloride, quantity: 38.13 mg (equivalent: thiamine, qty 30 mg); nicotinamide, quantity: 30 mg; mecobalamin, quantity: 75 microgram; calcium pantothenate, quantity: 32.75 mg (equivalent: pantothenic acid, qty 30 mg); d-alpha-tocopheryl acid succinate, quantity: 20.66 mg; inositol, quantity: 50 mg; selenomethionine, quantity: 161.5 microgram (equivalent: selenium, qty 65 microgram); folic acid, quantity: 400 microgram; manganese (ii) glycinate, quantity: 3.7 mg (equivalent: manganese, qty 1 mg); menaquinone 7, quantity: 90 microgram; zinc citrate dihydrate, quantity: 46.73 mg (equivalent: zinc, qty 15 mg); choline bitartrate, quantity: 243.13 mg (equivalent: choline, qty 100 mg); levomefolate glucosamine, quantity: 89 microgram (equivalent: levomefolic acid, qty 50 microgram); molybdenum trioxide, quantity: 75 microgram (equivalent: molybdenum, qty 50 microgram); calcium folinate, quantity: 54.3 microgram (equivalent: folinic acid, qty 50 microgram); calcium citrate tetrahydrate, quantity: 237.19 mg (equivalent: calcium, qty 50 mg); colecalciferol, quantity: 0.0125 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; silicon dioxide; chlorophyllin-copper complex; citric acid; crospovidone; microcrystalline cellulose; magnesium stearate; maltodextrin; colloidal anhydrous silica; povidone; medium chain triglycerides; carnauba wax; macrogol 400; pregelatinised rice starch; hypromellose; acacia; sodium ascorbate; d-alpha-tocopherol; fractionated coconut oil; liquid glucose - helps maintains/support healthy foetal cns/brain development ; maintains/support healthy foetal development ; maintain/support healthy pregnancy ; maintain/support maternal health ; decrease/reduce/relieve morning sickness ; help to prevent neural tube defects such as spina bifida and/or anencephaly ; helps enhance/promote preconception health ; maintain/support preconception health ; maintain/support placenta health/growth ; helps prepare the body for pregnancy ; maintain/support healthy thyroid gland function for pregnancy

Malta - English - Medicines Authority

renata pharmaceuticals (ireland) limited 13-18 city quay, dublin , dublin, d02ed70 , ireland - film-coated tablet - apixaban 2.5 mg - antithrombotic agents

Malta - English - Medicines Authority

renata pharmaceuticals (ireland) limited 13-18 city quay, dublin , dublin, d02ed70 , ireland - film-coated tablet - apixaban 5 mg - antithrombotic agents

Ireland - English - HPRA (Health Products Regulatory Authority)

renata pharmaceuticals (ireland) limited - hydrocortisone - tablet - 10 milligram(s) - glucocorticoids; hydrocortisone

Ireland - English - HPRA (Health Products Regulatory Authority)

renata pharmaceuticals (ireland) limited - hydrocortisone - tablet - 20 milligram(s) - glucocorticoids; hydrocortisone

Ireland - English - HPRA (Health Products Regulatory Authority)

renata (uk) limited - dipyridamole - prolonged-release capsule - 200 milligram(s) - platelet aggregation inhibitors excl. heparin; dipyridamole

United States - English - NLM (National Library of Medicine)

renata limited (general plant-2) - metoprolol tartrate (unii: w5s57y3a5l) (metoprolol - unii:geb06nhm23) - hypertension metoprolol tartrate tablets, usp are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents. angina pectoris metoprolol tartrate tablets, usp is indicated in the long-term treatment of angina pectoris. myocardial infarction metoprolol tartrate tablets, usp are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol. oral metoprolol tartrate tablets, usp therapy can be initiated after intravenous metoprolol therapy or, alternatively, oral treatment can begin within 3 to 10 days of the acute event (see dosage and administration, contraindications , and  warnings ). hypertension and angina metoprolol tartrate tablets, usp are contraindicated in sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure (see warnings ). hypersensitivity

Ireland - English - HPRA (Health Products Regulatory Authority)

renata (uk) limited - colchicine - tablet - 500 microgram(s) - preparations with no effect on uric acid metabolism; colchicine

Ireland - English - HPRA (Health Products Regulatory Authority)

renata pharmaceuticals (ireland) limited - dipyridamole ph eur - prolonged-release capsule, hard - 200 milligram(s) - platelet aggregation inhibitors excl. heparin; dipyridamole

Ireland - English - HPRA (Health Products Regulatory Authority)

renata (uk) limited - clindamycin hydrochloride - capsule, hard - 150 milligram(s) - clindamycin